Cargando…
Proteasome inhibitors in glioblastoma
Glioblastomas (GBM) are the tumors originating from the star shaped supportive cells in brain known as astrocytes. These tumors are highly cancerous as they have the ability to proliferate very quickly. New therapeutic strategies are being developed worldwide to fight against deadly GBM, which has m...
Autores principales: | Huang, Wen-Juan, Chen, Wei-Wei, Zhang, Xia |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
D.A. Spandidos
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5403505/ https://www.ncbi.nlm.nih.gov/pubmed/28454213 http://dx.doi.org/10.3892/ol.2017.5585 |
Ejemplares similares
-
Proteasome inhibitors in glioblastoma
por: Huang, Wen-Juan, et al.
Publicado: (2017) -
Glioblastoma multiforme: Effect of hypoxia and hypoxia inducible factors on therapeutic approaches
por: Huang, Wen-Juan, et al.
Publicado: (2016) -
Site-Specific Proteasome Inhibitors
por: Kisselev, Alexei F.
Publicado: (2021) -
Targeting the Ubiquitin-Proteasome System for Cancer Therapeutics by Small-Molecule Inhibitors
por: LaPlante, Gabriel, et al.
Publicado: (2021) -
Induction of cell death by the novel proteasome inhibitor marizomib in glioblastoma in vitro and in vivo
por: Manton, Christa A., et al.
Publicado: (2016)